A Turkish Patient With Succinyl-CoA:3-Oxoacid CoA Transferase Deficiency Mimicking Diabetic Ketoacidosis
Author(s) -
Şahin Erdöl,
Mehmet Türe,
Tahsin Yakut,
Halil Sağlam,
Hideo Sasai,
Elsayed Abdelkreem,
Hiroki Otsuka,
Toshiyuki Fukao
Publication year - 2016
Publication title -
journal of inborn errors of metabolism and screening
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.125
H-Index - 5
eISSN - 2326-4594
pISSN - 2326-4098
DOI - 10.1177/2326409816651281
Subject(s) - ketosis , ketoacidosis , ketone bodies , diabetic ketoacidosis , exon , endocrinology , compound heterozygosity , transferase , medicine , diabetes mellitus , ketogenic diet , chemistry , biochemistry , mutation , enzyme , psychiatry , gene , type 1 diabetes , metabolism , epilepsy
Succinyl-CoA:3-oxoacid CoA transferase (SCOT) deficiency is an autosomal recessive disorder of ketone body utilization that is clinically characterized with intermittent ketoacidosis crises. We report here the second Turkish case with SCOT deficiency. She experienced 3 ketoacidotic episodes: The first ketoacidotic crisis mimicked diabetic ketoacidosis because of the associated hyperglycemia. Among patients with SCOT deficiency, the blood glucose levels at the first crises were variable, and this case had the highest ever reported blood glucose level. She is a compound heterozygote with 2 novel mutations, c.517A>G (K173E) and c.1543A>G (M515V), in exons 5 and 17 of the OXCT1 gene, respectively. In patient’s fibroblasts, SCOT activity was deficient and, by immunoblot analysis, SCOT protein was much reduced. The patient attained normal development and had no permanent ketosis. The accurate diagnosis of SCOT deficiency in this case had a vital impact on the management strategy and outcome
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom